Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated

Jiri Eitler1,2, Natalie Wotschel1,2, Nicole Miller1,2

  • 1Experimental Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.

Abstract

Insights

Retargeting natural killer (NK) cells with chimeric antigen receptors (CARs) or antibody-dependent cell-mediated cytotoxicity (ADCC) overcomes tumor resistance by enabling lytic granule polarization. This targeted approach activates crucial signaling pathways, leading to effective cancer cell killing.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial for innate immunity, mediating cytotoxicity via directed degranulation.
  • NK cell retargeting strategies like CARs and mAbs show promise against resistant tumors.
  • Lytic granule dynamics in retargeted NK cells against resistant tumors remain poorly understood.

Purpose of the Study:

  • To investigate the lytic granule dynamics of retargeted NK cells against resistant cancer cells.
  • To elucidate the signaling pathways involved in NK cell-mediated cytotoxicity upon retargeting.
  • To determine if retargeting can overcome NK-cell resistance in specific cancer types.

Main Methods:

  • Live-cell imaging using spinning disk confocal microscopy.
  • Analysis of ErbB2-targeted CAR-expressing NK-92 cells and FcR transgenic NK-92 cells with Herceptin.
  • Coculture with ErbB2-positive, NK-resistant breast cancer cells (MDA-MB-453).

Main Results:

  • Unmodified NK-92 cells formed conjugates but failed to polarize granules to the immunological synapse (IS).
  • Retargeted NK cells (CAR or FcR+Herceptin) successfully polarized granules to the IS, leading to effective cytotoxicity.
  • Retargeting by CAR or ADCC provided essential PLCγ and MEK/ERK signaling, which were absent in unmodified NK-92 cells interacting with resistant cancer cells.

Conclusions:

  • NK cells require specific activation signals for granule polarization and effective cytotoxicity against resistant tumors.
  • CAR and FcR/mAb (ADCC) retargeting provide these necessary signals, overcoming tumor resistance.
  • Targeted NK cell therapies can be optimized by understanding and manipulating these signaling pathways.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
866
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
7.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
7.2K